日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bifidobacterium longum S-ribosylhomocysteine lyase (luxS) CSB-YP808357BGP
CSB-EP808357BGP
CSB-BP808357BGP
CSB-MP808357BGP
CSB-EP808357BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum 30S ribosomal protein S7 (rpsG) CSB-YP808358BGP
CSB-EP808358BGP
CSB-BP808358BGP
CSB-MP808358BGP
CSB-EP808358BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Arginine biosynthesis bifunctional protein ArgJ (argJ) CSB-YP808359BGP
CSB-EP808359BGP
CSB-BP808359BGP
CSB-MP808359BGP
CSB-EP808359BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Peptidyl-tRNA hydrolase (pth) CSB-YP808360BGP
CSB-EP808360BGP
CSB-BP808360BGP
CSB-MP808360BGP
CSB-EP808360BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Dephospho-CoA kinase (coaE) CSB-YP808361BGP
CSB-EP808361BGP
CSB-BP808361BGP
CSB-MP808361BGP
CSB-EP808361BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP808362BGP
CSB-EP808362BGP
CSB-BP808362BGP
CSB-MP808362BGP
CSB-EP808362BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum UPF0102 protein BL0935 (BL0935) CSB-YP808363BGP
CSB-EP808363BGP
CSB-BP808363BGP
CSB-MP808363BGP
CSB-EP808363BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Chorismate synthase (aroC) CSB-YP808364BGP
CSB-EP808364BGP
CSB-BP808364BGP
CSB-MP808364BGP
CSB-EP808364BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Aspartate carbamoyltransferase regulatory chain (pyrI) CSB-YP808365BGP
CSB-EP808365BGP
CSB-BP808365BGP
CSB-MP808365BGP
CSB-EP808365BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum GTPase Der (der) CSB-YP808366BGP
CSB-EP808366BGP
CSB-BP808366BGP
CSB-MP808366BGP
CSB-EP808366BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Probable transcriptional regulatory protein BL0726 (BL0726) CSB-YP808367BGP
CSB-EP808367BGP
CSB-BP808367BGP
CSB-MP808367BGP
CSB-EP808367BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Phosphoribosyl-AMP cyclohydrolase (hisI) CSB-YP808368BGP
CSB-EP808368BGP
CSB-BP808368BGP
CSB-MP808368BGP
CSB-EP808368BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum 50S ribosomal protein L34 (rpmH) CSB-YP808369BGP
CSB-EP808369BGP
CSB-BP808369BGP
CSB-MP808369BGP
CSB-EP808369BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Protease HtpX homolog (htpX), partial CSB-YP808370BGP1
CSB-EP808370BGP1
CSB-BP808370BGP1
CSB-MP808370BGP1
CSB-EP808370BGP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Recombination protein RecR (recR) CSB-YP808371BGP
CSB-EP808371BGP
CSB-BP808371BGP
CSB-MP808371BGP
CSB-EP808371BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Glutamyl-tRNA (Gln) amidotransferase subunit A (gatA), partial CSB-YP808372BGP
CSB-EP808372BGP
CSB-BP808372BGP
CSB-MP808372BGP
CSB-EP808372BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum ATP synthase subunit b (atpF), partial CSB-YP808373BGP1
CSB-EP808373BGP1
CSB-BP808373BGP1
CSB-MP808373BGP1
CSB-EP808373BGP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum ATP synthase subunit beta (atpD) CSB-YP808374BGP
CSB-EP808374BGP
CSB-BP808374BGP
CSB-MP808374BGP
CSB-EP808374BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum 30S ribosomal protein S16 (rpsP) CSB-YP808375BGP
CSB-EP808375BGP
CSB-BP808375BGP
CSB-MP808375BGP
CSB-EP808375BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum Non-canonical purine NTP pyrophosphatase (BL0285) CSB-YP808376BGP
CSB-EP808376BGP
CSB-BP808376BGP
CSB-MP808376BGP
CSB-EP808376BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×